Accessibility / Report Error
(Updated: 2022/10/18)

About the journal

 

Basic information

 

Please submit your manuscript electronically through the Editorial Manager Web site: http://www.editorialmanager.com/rbo

Revista Brazileira de Ortopedia (RBO)/Brazilian Journal of Orthopaedics is the Official Scientific Publication of the Brazilian Society of Orthopedics and Traumatology (Sociedade Brazileira de Ortopedia e Traumatologia, SBOT) and it aims to disseminate papers that contribute towards improving and developing the practice, research, and teaching of orthopaedics and related specialties.

It is published bimonthly in February, April, June, August, October, and December, and has been published regularly since its first edition in 1965.

The journal is dedicated to orthopaedists who are linked to the SBOT, healthcare professionals who are dedicated to similar activities, and orthopaedists in other countries.

 

 

Indexing sources

 
  • PubMed Central (PMC)
  • Scopus
  • Scimago
  • SciELO (Scientific Electronic Library Online)
  • EBSCO
  • ProQuest
  • LILACS/BVS (Literatura Latino-Americana e do Caribe em Ciências da Saúde, Index Medicus Latino Americano / Biblioteca Virtual em Saúde)
  • Portal de Periódicos Capes (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior)

RBO requires that authors follow the ICMJE (International Committee of Medical Journal Editors) recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals. More information can be found here: http://www.icmje.org

 

 

Intellectual property

 

Articles are published under the "CC-BY-NC-ND 4.0" license.  This means that everyone is free to copy, distribute and transmit the published article. Commercial use is not allowed, nor are derivative works (nobody may alter, transform, or build upon your work without express permission). The full text of the license can be found at creativecommons.org/licenses/by-nc-nd/4.0/deed.en.

 

 

Sponsors

 
  • RBO does not receive any financing money from development agencies. The Brazilian Society of Orthopedics and Traumatology is the sponsor, but the journal carries paid publicity.
  • The RBO not charge any fees for submission and publication of their articles.
  • Neither the journal nor the Society object to the inclusion of links and institutional logos required to give more visibility to the journal or to the database.

 

 


Editorial board

Editor in chief

   

 

Emeritus Editors

 
  • Márcio Ibrahim de Carvalho (In memoriam)
  • Donato D´Angelo (In memoriam)
  • Carlos Giesta (https://orcid.org/0000-0002-3242-900X)
    Universidade Federal do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil
  • Gilberto Luís Camanho (https://orcid.org/0000-0001-8656-5552)
    Instituto de Ortopedia e Traumatologia da FMUSP, Departamento de Ortopedia e Traumatologia, HCFMUSP, São Paulo, SP, Brazil
 

 

Associated Editors

   

 

Junior Editor

   

 

International Editors

   

 

Editorial Board

   

 

Consultant Board

   

 


Instructions to authors

 

 

Thank you for contributing to Revista Brasileira de Ortopedia. Please read the instructions carefully and observe all the directions given. Failure to do so may result in unnecessary delays in publishing your article.

APC Type

2022 Article Processing Charge (APC)

Regular

None (Society Funded)

 

Find out more about Open Access at Thieme

SUBMISSION CHECKLIST

All manuscripts must be submitted at the following link:
http://www.editorialmanager.com/rbo

  • AUTHOR INFORMATION
    • All authors: full name, department, affiliation
    • Corresponding author: full name, degrees, department, affiliation, mailing address, telephone and fax number, e-mail address
  • MANUSCRIPT FILE
    • Must be digital - hard copy submissions are not accepted
  • ABSTRACT AND KEYWORDS
    • See the section Article Types for word limit
  • REFERENCES
    • Cited sequentially in Vancouver
  • FIGURES AND TABLES
    • Cited sequentially in the main document, must be saved separately from the main document
  • ART FILES
    • Must be saved separately from the main document
  • PERMISSIONS
    • Required if you plan to reproduce content from a published source or include a photograph of a patient
    • Patient permission form forms available at www.thieme.com

The Revista Brasileira de Ortopedia (RBO) is the Official Scientific Publication of the Brazilian Society of Orthopedics and Traumatology (Sociedade Brasileira de Ortopedia e Traumatologia, SBOT) and it aims to disseminate papers that contribute towards improving and developing the practice, research and teaching of orthopedics and related specialties. It is published bimonthly in February, April, June, August, October and December, and has been published regularly since its first edition in 1965. The journal is dedicated to orthopedists who are linked to the SBOT, healthcare professionals who are dedicated to similar activities and orthopedists in other countries.

Peer Reviewing Process

The journal follows a double-blind peer-review process where neither author nor reviewer does not get to know the identity of each other.

At least two random reviewers based on their technical and clinical expertise are assigned by the Chief Editor on each manuscript. The decision is taken based on the comparative reviews that the manuscript receives during the review process.

MANUSCRIPT FORMAT

Article Types

The following graph shows what types of articles are accepted for publication, and what requirement they may have.


Article Type

Abstract Limit

Keywords Limit

Title Limit

Figures/Tables

Reference

Original Article
(Up to 2,500 words)

Up to 250 words

Up to 6 N/A

10 Figures
e 6 Tables

Up to 30
References

Update Articles
(Up to 4,000 words)

Up to 250 words

Up to 6 N/A

3 Figures and
2 Tables

Up to 60
References

Systematic Reviews and Meta-analysis
(Up to 4,000 words)

Up to 250 words

Up to 6 N/A

3 Figures
e 2 Tables

Up to 60
References

Systematic Review Protocol (Up to 2,500 words)

Up to 250 words

Up to 6

N/A

N/A

Up to 20 References

Case Report
(Up to1,000 words)

Up to 250 words

Up to 6 N/A

5 Figures

Up to 10
References

Technical Notes
(Up to 1,500 words)

Up to 250 words

Up to 6 N/A

5 Figures
e 2 Tables

Up to 8
References

Letters to the Editor
(Up to 500 words

N/A

N/A

N/A

2 Figures

Up to 4
References

Editorial (Up to 500 words)

N/A

N/A

N/A

N/A

N/A

 

Original Article: It describes prospective or retrospective experimental research or clinical investigations, which may be randomized or double blind. It should have a Title, Structured Abstract (Objective, Methods, Results, and Conclusion), keywords, introduction, materials and methods, results, discussion, conclusions and references. Can have maximum of 6 authors. Maximum of 2,500 words, 30 references, 10 figures and 6 tables.

Update Articles: These are reviews of the state of the art on a given topic, written by specialists on invitation from the Editor-in-Chief. They should have Title, Unstructured abstract keywords, and references. Maximum of 4,000 words, 60 references, 3 figures and 2 tables.

Systematic Reviews and Meta-analysis: These have the purpose of examining the published bibliography on a given subject, in order to make a critical and systematized assessment on a certain specific topic and present the important conclusions based on this literature. They should have Title, an Unstructured abstract, keywords, and references. Maximum of 4,000 words, 60 references, 3 figures and 2 tables.

Systematic Review Protocol: The protocol can be published in article format. Must contain the strategies methodologies for carrying out the systematic review and must contain at least the following information: a search strategy to identify articles of interest, eligibility criteria, data extracted, the variables of interest, data analysis, and forms to explore heterogeneities. The essential items inherent in performing a systematic review may be seen at the link: https://tinyurl.com/. RBO suggests that all researchers register the protocol of their systematic reviews in Prospero or PRISMA. The protocol will be evaluated by the journal's editorial board and submitted to the peer-review process.

Case Report: It should be informative and should not contain irrelevant details. Only clinical case reports of interest, either for its rarity as a nosological entity, or for the unusual form of presentation. It should have a title,  unstructured abstract, keywords and references. Maximum of 1,000 words, 10 references, 5 figures.

Technical Note: Intended for the disclosure of diagnostic method or experimental surgical technique, new surgical instruments, orthopedic implants, etc. Must have: Title; unstructured abstract; Keywords; Explanatory Introduction, Method, Material or Technique Description, Final Comments and References. Maximum of 1.500 words, 8 references, 5 figures and 2 tables.

Letters to the Editor: These have the aim of commenting on or discussing studies published in the journal or reporting on original research that is in progress. They will be published at the editors' discretion, with the respective reply, when appropriate.

Editorial: These are written on invitation from the Editor-in-Chief, presenting comments on important studies in this journal, describing important published research or presenting communications from the editors that are of interest to the specialty.

General Guidelines

  • You must submit a digital copy of your manuscript. Hard copy submissions are not accepted.
  • Keep the format of your manuscript simple and clear. We will set your manuscript according to our style—do not try to “design” the document.
  • The manuscript, including the title page, abstract and keywords, text, references, figure captions, and tables should be typewritten, double-spaced in 12-point font with 1-inch margins all around and saved as one file.
  • Each figure should be saved as its own separate file. Do not embed figures within the manuscript file. This requires special handling by Thieme’s Production Department.
  • Keep abbreviations to a minimum and be sure to explain all of them the first time they are used in the text.
  • The manuscripts should be written in consistent British or American English.
  • The authors should use Système International (SI) measurements. For clarity, nonmetric equivalents may be included in parentheses following the SI measurements.
  • Use generic names for drugs. You may cite proprietary names in parentheses along with the name and location of the manufacturer.
  • Credit suppliers and manufacturers of equipment, drugs, and other brand-name material mentioned in the manuscript within parentheses, giving the company name and primary location.

Files/Information Checklist:

  • One of the authors can be designated as the corresponding author. The e-mail address and full postal address should be included in the title page. For more details, please see below the section of Title Page.
  • Manuscript:
    • Include Keywords
    • All relevant Figures and their Figure captions/legends
    • All Tables (including titles, description, footnotes)
    • Ensure all fi gure and table citations in the text match the fi les provided
    • Indicate clearly if color should be used for any fi gures in print Graphical Abstracts / Highlights fi les (wherever applicable)
    • Supplemental fi les (wherever applicable)
  • Further considerations
    • Manuscript has been ‘spell checked’ and ‘grammar checked’
    • All references mentioned in the Reference List are cited in the text, and vice versa
    • Permission has been obtained for use of copyrighted material from other sources (including the Internet)
    • A competing interests statement is provided, even if the authors have no competing interests to declare
    • Journal policies detailed in this guide have been reviewed

Language

Articles can be written in Portuguese or English.

Title Page

  • This journal adheres to a double-blinded peer-review policy. The title page should not be included in the main document and should be provided as a separate document.
  • Article Title: Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
  • Authorship: A maximum of 6 authors, except to the multicenter studies where the number of authors may be greater, as follows:
    • Two or three institutions, a maximum of 4 authors per institution;
    • More than four institutions, a maximum of 3 authors per institution.
    • Under no circumstances, the number of authors can be greater than 20.
  • Indicate professional qualification, academic degree, and affiliation of each author, separately. If there is more than one institutional affiliation, indicate only the most relevant. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Present the authors’ affiliation addresses (where the actual work was done) below each name, followed by the respective ORCID. Indicate all affiliations with a lower-case superscript letter immediately after the author’s name and in front of the appropriate address. Provide the full postal address of each affiliation, including the city, state, and country name and, if available, the e-mail address of each author. Author affiliations should be presented in increasing hierarchical order (e.g. Harvard University, Harvard Business School, Boston, USA) and should be written as established in its own language (e.g. Universit Paris-Sorbonne; Harvard University, Universidade de São Paulo).
  • Corresponding Author: Clearly indicate who will handle correspondence at all stages of refereeing and publication, also postpublication. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

Abstract and Keywords

See the section Article Types for word limits. The abstract should briefly outline the content of the article and any conclusions it may reach. The keywords should be words a reader would be likely to use in searching for the content of the article. A structured abstract, by means of appropriate headings, should provide the context or background for the research and should state its purpose, basic procedures (selection of study subjects or laboratory animals, observational and analytical methods), main findings (giving specific effect sizes and their statistical significance, if possible), and principal conclusions. It should emphasize new and important aspects of the study or observations.

The abstracts should be a maximum of 250 words and structured in the following format: Purpose: One or two sentences that simply state purpose with no background information. Methods: Provide details about the methods of the study, including data analysis. Results: Present most important findings of the study. Please provide numbers (means with standard deviations or medians with ranges) to support your findings, and results of significance tests, e.g. p-values. Conclusions: One or two sentences that state only what your study identified and demonstrated. Please do not include comments or information not supported by the data of your study. Level of Evidence (for human studies) or Clinical relevance (basic science in-vitro or in-vivo study: why is this study important from a clinical standpoint?). Immediately after the abstract, provide a maximum of 6 keywords in alphabetical order and separated by semicolon, to represent the content of the article. The descriptors or keywords should be based on the Health Science Descriptors (Descritores em Cincias da Sade, DECS), which are available at the electronic address https://decs.bvsalud.org/; or on the Medical Subject Headings (MeSH), from www.nlm.nih.gov/mesh/MBrowser.html.

Main Document

  • This journal uses double-blind peer-review, which means the identities of the authors are concealed from the reviewers, and vice versa. To facilitate this, please include the following separately:
    • Title page (with author details): This should include the title, professional qualification, academic title and affiliation of each author, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.
    • Blinded manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors’ names or affiliations.
  • Original Articles, Systematic Reviews and Meta-analyses, the text should be structured in the standard IMRAD (Introduction, Methods, Results, Discussion) format.
  • Papers including human, or animal subjects must include a statement of approval by appropriate agencies in the text.
  • Use generic names of drugs or devices. If a particular brand was used in a study, insert the brand name along with the name and location of the manufacturer in parentheses after the generic name when the drug or device is first mentioned in the text.
  • Quantities and units should be expressed in accordance with the recommendations of the International System of Units (SI), 8th edition 2006.
  • When abbreviations are used, give the full term followed by the abbreviation in parentheses the first time it is mentioned in the text, such as inferior gleno-humeral ligament (IGHL).
  • Please clearly distinguish the hierarchy of headings within the manuscript by using capital letters, underline, italic, and bold styles as necessary.
  • As needed, use italic, superscripts, subscripts, and boldface, but otherwise do not use multiple fonts and font sizes..
  • Use hard returns (the Enter key) only at the end of a paragraph, not at the end of a line. Allow lines of text to break automatically in your word-processing software. Do not justify your text.
  • Use only one space, not two, after periods.
  • Create tables using the Table function in Microsoft Word.

Acknowledgments

Collate acknowledgements in a separate section at the end of the article before the references and do not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those individuals who provided help during the research (e.g., providing language help, writing assistance or proofreading the article, etc.).

Formatting of Funding Sources

List funding sources in this standard way to facilitate compliance to funder’s requirements:

Funding: This work was supported by the National Institutes of Health [grant numbers xxxx, yyyy]; the Bill & Melinda Gates Foundation, Seattle, WA [grant number zzzz]; and the United States Institutes of Peace [grant number aaaa]. It is not necessary to include detailed descriptions on the program or type of grants and awards. When funding is from a block grant or other resources available to a university, college, or other research institution, submit the name of the institute or organization that provided the funding. If no funding has been provided for the research, please include the following sentence:

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Preprint Server Statement

RBO encourages the submission of manuscripts that have been deposited in an initial draft version in preprint repositories such as Research Square, arXiv, and medRxiv. Drafts of short conference abstracts or degree theses posted on the website of the degree-granting institution, and draft manuscripts deposited on authors’ or institutional websites are also welcome. All other prior publication is forbidden.

During submission, authors should:

(1) note use of the preprint repository in the cover letter;

(2) state what adjustments and/or updates the draft has undergone between deposition and submission;

(3) cite the preprint, including the DOI, as a reference in the manuscript.

After submission to the journal, and until a final decision has been made, authors are discouraged from depositing versions of their manuscript as preprints. Upon publication authors should add a link from the preprint to the published article. Twelve months after publication, authors can update the preprint with the accepted manuscript.

Conflict of Interest Statement

All authors (including corresponding and co-authors associated with the manuscript) must make a formal statement at the time of submission indicating any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication. Click conflicts-ofinterest to download a conflict of interest form. Disclosure information is important in article processing. If the forms provided are incomplete or missing, this may cause delays in the publication of the article. Should the article be accepted for publication, this information will be published with the paper.

Informed Consent

The journal adheres to the principles set forth in the Helsinki Declaration and holds that all reported research conducted with human participants should be conducted in accordance with such principles. Reports describing data obtained from research conducted in human participants must contain a statement in the Methods section indicating approval by the Institutional Review Board (IRB). The authors should also indicate whether individual consent for the study was obtained, or whether it was waived.

References

References should be the most recent and pertinent literature available. It is essential that they are complete and thoroughly checked. If the reference information is incomplete, good online sites to search for full details are the National Library of Medicine; Books in Print; PubMed; or individual publisher Web sites.

  • References must be listed in AMA style, using Index Medicus journal title abbreviations.
  • References follow the article text. Insert a page break between the end of text and the start of references.
  • References must be cited sequentially (NOT alphabetically) in the text using superscript numbers.
  • List all author names, up to and including six names. For more than six authors, list the first three followed by et al.
  • References should be styled per the following examples:

1. Citing a journal article:

Borges JLP, Milani C, Kuwajima SS, Laredo Filho J. Tratamento da luxação congênita de quadril com suspensório de Pavlik e monitorização ultrassonográfica. Rev Bras Ortop 2002;37(1/2):5-12

2. Citing a chapter in a book:

Johnson KA. Posterior tibial tendon. In: Baxter D. The foot and ankle in sport. St Louis: Mosby; 1995. p. 43-51

3. Citing a book:

Baxter D. The foot and ankle in sport. St Louis: Mosby; 1995

4. Citing a thesis:

Laredo Filho J. Contribuição ao estudo clínico-estatístico e genealógico-estatístico do pé torto congênito equinovaro [thesis]. São Paulo: Universidade Federal de São Paulo. Escola Paulista de Medicina; 1968

5. Citing a government publication:

Food and Drug Administration. Jin Bu Huan Herbal Tablets. Rockville, MD: National Press Office; April 15, 1994. Talk Paper T94-22

6. Citing an online article:

Lino Junior W, Belangero WD. Efeito do Hólmio YAG laser (Ho: YAG) sobre o tendão patelar de ratos após 12 e 24 semanas de seguimento. Acta Ortop Bras [periodical on the Internet] 2005 [cited 2005, Aug 27];13(2):[about 5 p.]. Available from: http://www.scielo.br/scielo

7. Citing a symposium article:

Eisenberg J. Market forces and physician workforce reform: why they may not work. Paper presented at: Annual Meeting of the Association of American Medical Colleges; October 28, 1995; Washington, DC

Figure Captions

  • Figures include photographs or radiographs, drawings, graphs, bar charts, flow charts, and pathways, but NOT lists or tables.
  • Figures must be cited sequentially in the text. Number all figures (and corresponding figure captions) sequentially in the order they are cited in the text.
  • Figure captions should be written after the reference list. Insert a page break between the end of references and the start of figure captions.
  • Figure captions should include a description of the figure and/or each lettered part (A, B, etc.) and of any portions of the figure highlighted by arrows, arrowheads, asterisks, etc.
  • For a figure borrowed or adapted from another publication (used with permission), add a credit line in parentheses at the end of each figure legend. This credit line should be a complete bibliographic listing of the source publication (as a reference), or other credit line as supplied by the copyright holder. For example (Reprinted with permission from Calfee DR, Wispelwey B. Brain abscess. Semin Neurol 2000;20:357.)

Tables

  • Data given in tables should be commented on but not repeated in the text. Be sure that lists or columns of related data are composed in a word-processing program like the rest of the text.
  • Do not intersperse tables in the text. Tables should appear after the figure captions. Insert a page break between the end of the figure captions and the start of the tables.
  • Tables must be double-spaced and numbered in the same sequence they are cited in the text. A short descriptive title should be provided for each table.
  • If a table contains artwork, supply the artwork separately as a digital file.
  • For tables borrowed or adapted from another publication (used with permission), add a credit line as the first footnote beneath each table. This credit line should be a complete bibliographical listing of the source publication (as a reference), or other credit line as supplied by the copyright holder. For example, “Reprinted with permission from Calfee DR, Wispelwey B. Brain abscess. Semin Neurol 2000;20:357.” (“Data from . . .” or “Adapted from . . .” may also be used, as appropriate.)
  • Other footnotes for tables should be indicated in the table using superscript letters in alphabetical order.
  • Any abbreviations used in the table should be explained at the end of the table in a footnote.

Videos

  • The following formats are acceptable: *.avi, *.mov and *.mpg.
  • For supplementary videos, the length should not exceed 4 minutes, and a legend of no more than 40 words per video or per sequence is required (it should also be included in the main document).
  • If including a voice over, it must be in clear English. Be precise, informative, and clear in your speech. Re-record audio in post-production for sound quality.

Supplementary Material

Supplementary material such as applications, images, and sound clips, can be published with your article to enhance it. Submitted supplementary items are published exactly as they are received (Excel or PowerPoint fi les will appear as such online). Please submit your material together with the article and supply a concise, descriptive caption for each supplementary fi le. If you wish to make changes to supplementary material during any stage of the process, please make sure to provide an updated file. Do not annotate any corrections on a previous version. Please switch off the ‘Track Changes’ option in Microsoft Office fi les as these will appear in the published version.

DIGITAL ARTWORK PREPARATION

General Guidelines

  • It is best to use Adobe Photoshop to create and save images, and Adobe Illustrator for line art and labels.
  • Do not submit art created in Microsoft Excel, Word, or PowerPoint. These files cannot be used by the typesetter.
  • Save each figure in a separate file.
  • Do not compress files.
  • All black-and-white and color artwork should be at a resolution of 300 dpi (dots per inch) in TIFF format. Line art should be 1,200 dpi in EPS or TIFF format. Contact the Production Editor at Thieme if you are unsure of the final size.
  • It is preferable for figures to be cropped to their final size (approximately 3½ inches for a single column and up to 7 inches for a double column), or larger, and in the correct orientation. If art is submitted smaller and then has to be enlarged, its resolution (dpi) and clarity will decrease.

Note: Lower resolutions (less than 300 dpi) and JPEG format (.jpg extension) for grayscale and color artwork are strongly discouraged due to the poor quality they yield in printing, which requires 300 dpi resolution for sharp, clear, detailed images. JPEG format, by definition, is a lower resolution (compressed) format designed for quick upload on computer screens.

Black-and-White Art

  • Black-and-white artwork can be halftone (or grayscale) photographs, radiographs, drawings, line art, graphs, and flowcharts. Thieme will only accept digital artwork.
  • If possible, do not send color art for conversion to black-and-white. Do the conversion yourself so that you can check the results and confirm in advance that no critical details are lost or obscured by the change to black-and-white.
  • For best results, line art should be black on a white background. Lines and type should be clean and evenly dark. Avoid screens or cross-hatching, as they can darken or be uneven in printing and lead to unacceptable printing quality.

Color Art

  • All color artwork should be saved in CMYK, not RGB.

Art Labels

  • Arrows, asterisks, and arrowheads (or other markers) should be white in dark or black areas and black in light or white areas, and large in size. If not, these highlighting marks may become difficult to see when figures are reduced in size during the typesetting process.
  • Capitalize the first word of each label and all proper nouns. Consider using all capitals if you need a higher level of labels.
  • Where there are alternate terms or spellings for a named structure, use the most common one and make sure it is consistent with what is used in the text.
  • Avoid using multiple fonts and font sizes for the labels; use only one or two sizes of a serif font.

SUBMISSION PROCEDURE

Article Processing Charge (APC) & Open Access

This is a subsidized Open Access journal: all the articles after publishing online, will be immediately and permanently made free for everyone to read and download on Thieme-connect platform. The Brazilian Society of Orthopaedics and Traumatology (Sociedade Brasileira de Ortopedia e Traumatologia SBOT) pays for the publishing costs incurred by the journal. Authors do not have to pay any Article Processing Charge or Open Access Publication Fee. All peer- reviewed articles are published as open access in this journal. Permitted third party (re)use is defined by the following Creative Commons user licenses: Creative Commons Attribution-Non Commercial-No Derivs (CC BY-NC-ND)

For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work (such as an anthology), as long as they credit the author(s) and provided they do not alter or modify the article.

Submission Procedure

  • Consult the checklist on the first page of this document to ensure that you are ready to submit your manuscript.
  • Manuscripts must be submitted electronically at the following link: http://www.editorialmanager.com/rbo
  • Always review your manuscript before submitting it. You may stop a submission at any phase and save it to submit later. After submission, you will receive a confirmation email. You can also check the status of your manuscript by logging in to the submission system. The system converts your article files to a single PDF file used in the peer-review process. Editable files are required to typeset your article for final publication. All correspondence, including notification of the Editor’s decision and requests for revision, is sent by e-mail. The Editor in Chief will inform you via email once a decision has been made.

Revision Procedure

  • Should the editors decide that your article requires a revision, you will need to make the changes via a word-processing program and resubmit it electronically.
  • Log In to the submission system and find your article, which will be marked for revision.
  • The best way to make revisions to your manuscript is by enabling the Track Changes mode in Microsoft Word, which will automatically highlight and mark up revised text. Please submit both a marked up copy and a clean copy of your revised manuscript to the submission system.
  • Your original files will still be available after you upload your revised manuscript, so you should delete any redundant files before completing the submission.
  • You will also be provided space in which to respond to the reviewers’ and editors’ comments. Please be as specific as possible in your response.

PRODUCTION PROCEDURE

Page Proofs

Page proofs will be sent to you via email. The proofs will be in a PDF file format, which should be opened using Acrobat Reader software. You will receive further instructions with your proofs. Take this opportunity to check the typeset text for typographic and related errors. Elective alterations are difficult to accommodate owing to the associated time and expense of introducing them. Therefore, please be sure that when you submit your manuscript, it is accurate, complete, and final.

POLICY STATEMENTS

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Ethics standards

No data or image identifying a patient can be used without formal consent (patient permission forms are available at: www.thieme.com); studies using human beings or animal trials must follow ethical standards from the International Committee of Medical Journals Editors – ICMJE, as well as approval of original institution’s Ethics Committee; conflicts of interest must have a ICMJE form filled in by all authors (available at: http://icmje.org/); commercial marks should be avoided; authors are the sole responsible for opinions and concepts in the published articles, as well as for the reference accuracy.

Authorization Letter

The corresponding author should send a letter authorizing publication, signed by all coauthors, ensuring the uniqueness of the publication, i.e., the article should not be posted on other news outlets, not be available online. Articles already published in other media should say when and where they were accepted for publication.

Conflict of Interest Statement (if any):

All authors (including corresponding and coauthors associated with the manuscript) must make a formal statement at the time of submission indicating any potential conflict of interest that might constitute an embarrassment to any of the authors if it were not to be declared and were to emerge after publication. Such conflicts might include, but are not limited to, shareholding in or receipt of a grant or consultancy fee from a company whose product features in the submitted manuscript or which manufactures a competing product. Should the article be accepted for publication, this information will be published with the paper.

Types of conflicts include: Consulting, Royalties, Research Support, Institutional Support, Ownership, Stock/Options, Speakers Bureau, and Fellowship Support. Any commercial entity whose products are described, reviewed, evaluated, or compared in the manuscript, except for those disclosed in the Acknowledgments section, are potential conflicts. This journal follows the guidelines of the International Committee of Medical Journal Editors and an ICMJE disclosure of potential conflicts of interest (COI) form must be submitted for each author at the time of manuscript submission. Forms must be submitted even if there is no conflict of interest. It is the responsibility of the corresponding author to ensure that all authors adhere to this policy prior to submission.

A conflict-of-interest statement must also be included in the manuscript after any "Acknowledgements" and "Funding" sections and should summarize all aspects of any conflicts of interest included on the ICMJE form. If there is no conflict of interest, authors must include 'Conflict of Interest: none declared'. Please click to download a Conflict-of-Interest form. The disclosure information is important in article processing. If the provided forms are incomplete or missing, it can cause delays in publishing of article.

Copyright Statement

Submitted manuscripts must represent original research not previously published nor being considered for publication elsewhere.

The editors and Thieme combat plagiarism, double publication, and scientific misconduct with the software Cross-Check powered by iThenticate. Your manuscript may be subject to an investigation and retraction if plagiarism is suspected.

If you plan to reproduce text, tables, or figures from a published source, you must first obtain written permission from the copyright holder (usually the Society). This is required even if the material is from your own published work. For material never published and given to you by another person, you must obtain permission from that person. Serious delays to publication can be incurred if permissions are not obtained. As the author, it is your responsibility to obtain all permissions, pay any permission fees, furnish copies of permissions to Thieme with your manuscript, and include a credit line at the end of the figure caption, beneath the table, or in a text footnote. Articles are published under the "CC-BY-NC-ND 4.0" license.  This means that everyone is free to copy, distribute and transmit the published article. Commercial use is not allowed, nor are derivative works (nobody may alter, transform, or build upon your work without express permission). The full text of the license can be found at creativecommons.org/licenses/by-nc-nd/4.0/deed.en.

Informed Consent

The journal adheres to the principles set forth in the Helsinki Declaration and holds that all reported research conducted with human participants should be conducted in accordance with such principles. Reports describing data obtained from research conducted in human participants must contain a statement in the Methods section indicating approval by the Institutional Review Board (IRB). The authors should also indicate whether individual consent for the study was obtained, or whether it was waived.

Definition of Authorship

Authorship credit should be based on criteria established by the International Committee of Medical Journal Editors. Each author should have made the following contributions towards the completion of the manuscript:

1. Substantial contributions to conception and design, acquisition of data, or analysis and  interpretation of data

2. Drafting the article or revising it critically for important intellectual content

3. Final approval of the version to be published

Contributors

Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described. The statement that all authors have approved the final article should be true and included in the disclosure.

Changes to authorship

Authors are expected to carefully consider the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion, or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal, or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Only in exceptional circumstances will the Editor consider the addition, deletion, or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

EDITORIAL CONTACTS

Please contact the Editors or Thieme Publishers with any questions.

Editor in Chief
Prof. Dr. Sergio L Checchia, MD, PhD
Sociedade Brasileira de Ortopedia e Traumatologia
Alameda Lorena, 427 – 2º . Andar - Jd. Paulista, SP, Brazil
rbo@sbot.org.br
T: +55 11 2137 5400

Thieme Publishers
Acquisitions Editor
Ana Bluhm, MSc., PhD
ana.bluhm@thieme.com.br

Production Coordinator
Gisele Múfalo
gisele.mufalo@thieme.com.br

Junior Production Coordinator
Paula Di Sessa Vavlis
paula.disessa@thieme.com.br

 
Sociedade Brasileira de Ortopedia e Traumatologia Al. Lorena, 427 14º andar, 01424-000 São Paulo - SP - Brasil, Tel.: 55 11 2137-5400 - São Paulo - SP - Brazil
E-mail: rbo@sbot.org.br